Ezra Cohen to Drug Monitoring
This is a "connection" page, showing publications Ezra Cohen has written about Drug Monitoring.
Connection Strength
0.197
-
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors. J Immunother Cancer. 2019 12 04; 7(1):342.
Score: 0.163
-
Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clin Cancer Res. 2017 Aug 15; 23(16):4716-4723.
Score: 0.034